UBS Group’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

UBS Group’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,562	Closed	-$14K	–	11745
2022 Q1	$14K	Sell	4,562 -14,078	-76%	-$31K	﹤0.01%	8019
2021 Q4	$24K	Buy	+18,640	New	+$37.4K	﹤0.01%	7663
2021 Q3	–	Sell	-47,670	Closed	-$271K	–	10578
2021 Q2	$271K	Buy	47,670 +4,374	+10%	+$29.1K	﹤0.01%	5144
2021 Q1	$272K	Buy	43,296 +12,449	+40%	+$93.4K	﹤0.01%	5270
2020 Q4	$242K	Buy	+30,847	New	+$273K	﹤0.01%	5121

UBS Group's TLMD Position: Q2 2022 in Review

UBS Group sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 4,562 shares — an estimated $14K sold.

UBS Group first reported a position in TLMD in Q4 2020 and held it in 5 quarters. The position peaked at $272K in Q1 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

UBS Group reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
UBS Group sold 4,562 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $14K.
UBS Group first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 5 quarters.
UBS Group's SOC Telemed, Inc. Class A Common Stock position peaked at $272K in Q1 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.